LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | Dovitinib | 0.12 | uM | LJP5 | 1 | E23 | 72 | hr | 1209 | 3814 | 3980 | 0.9583 | 0.9510 |
MCF7 | Dovitinib | 0.12 | uM | LJP5 | 2 | E23 | 72 | hr | 1209 | 3754 | 4252 | 0.8827 | 0.8671 |
MCF7 | Dovitinib | 0.12 | uM | LJP5 | 3 | E23 | 72 | hr | 1209 | 4088 | 4376 | 0.9342 | 0.9279 |
MCF7 | Dovitinib | 0.37 | uM | LJP5 | 1 | E22 | 72 | hr | 1209 | 2669 | 3980 | 0.6706 | 0.5850 |
MCF7 | Dovitinib | 0.37 | uM | LJP5 | 2 | E22 | 72 | hr | 1209 | 2379 | 4252 | 0.5594 | 0.4520 |
MCF7 | Dovitinib | 0.37 | uM | LJP5 | 3 | E22 | 72 | hr | 1209 | 3074 | 4376 | 0.7025 | 0.6533 |
MCF7 | Dovitinib | 1.11 | uM | LJP5 | 1 | E21 | 72 | hr | 1209 | 1858 | 3980 | 0.4668 | 0.2838 |
MCF7 | Dovitinib | 1.11 | uM | LJP5 | 2 | E21 | 72 | hr | 1209 | 2099 | 4252 | 0.4936 | 0.3551 |
MCF7 | Dovitinib | 1.11 | uM | LJP5 | 3 | E21 | 72 | hr | 1209 | 2246 | 4376 | 0.5132 | 0.3960 |
MCF7 | Dovitinib | 3.33 | uM | LJP5 | 1 | E20 | 72 | hr | 1209 | 1570 | 3980 | 0.3945 | 0.1639 |
MCF7 | Dovitinib | 3.33 | uM | LJP5 | 2 | E20 | 72 | hr | 1209 | 1775 | 4252 | 0.4174 | 0.2355 |
MCF7 | Dovitinib | 3.33 | uM | LJP5 | 3 | E20 | 72 | hr | 1209 | 1726 | 4376 | 0.3944 | 0.2113 |
MCF7 | Dovitinib | 10 | uM | LJP5 | 1 | E19 | 72 | hr | 1209 | 1613 | 3980 | 0.4053 | 0.1824 |
MCF7 | Dovitinib | 10 | uM | LJP5 | 2 | E19 | 72 | hr | 1209 | 1580 | 4252 | 0.3715 | 0.1587 |
MCF7 | Dovitinib | 10 | uM | LJP5 | 3 | E19 | 72 | hr | 1209 | 1769 | 4376 | 0.4042 | 0.2274 |
MCF7 | GSK 690693 | 0.04 | uM | LJP5 | 1 | F24 | 72 | hr | 1209 | 2634 | 3980 | 0.6618 | 0.5729 |
MCF7 | GSK 690693 | 0.04 | uM | LJP5 | 2 | F24 | 72 | hr | 1209 | 2775 | 4252 | 0.6525 | 0.5806 |
MCF7 | GSK 690693 | 0.04 | uM | LJP5 | 3 | F24 | 72 | hr | 1209 | 2975 | 4376 | 0.6798 | 0.6244 |
MCF7 | GSK 690693 | 0.12 | uM | LJP5 | 1 | F23 | 72 | hr | 1209 | 2308 | 3980 | 0.5799 | 0.4565 |
MCF7 | GSK 690693 | 0.12 | uM | LJP5 | 2 | F23 | 72 | hr | 1209 | 2214 | 4252 | 0.5206 | 0.3955 |
MCF7 | GSK 690693 | 0.12 | uM | LJP5 | 3 | F23 | 72 | hr | 1209 | 2337 | 4376 | 0.5340 | 0.4262 |
MCF7 | GSK 690693 | 0.37 | uM | LJP5 | 1 | F22 | 72 | hr | 1209 | 1936 | 3980 | 0.4864 | 0.3149 |
MCF7 | GSK 690693 | 0.37 | uM | LJP5 | 2 | F22 | 72 | hr | 1209 | 1827 | 4252 | 0.4296 | 0.2553 |
MCF7 | GSK 690693 | 0.37 | uM | LJP5 | 3 | F22 | 72 | hr | 1209 | 2266 | 4376 | 0.5178 | 0.4027 |
MCF7 | GSK 690693 | 1.11 | uM | LJP5 | 1 | F21 | 72 | hr | 1209 | 1890 | 3980 | 0.4749 | 0.2966 |